Utility of Tumor Suppressor E2F Target Gene Promoter Elements to Drive Gene Expression Specifically in Cancer Cells

Kenta Kurayoshi1, Masakazu Tanaka2, Rinka Nakajima1

  • 1Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, 1 Gakuen Uegahara, Sanda 669-1330, Hyogo, Japan.

Cells
|December 24, 2025
PubMed

Insights

Researchers developed novel artificial promoters using tumor suppressor gene elements. These promoters show high specificity for cancer cells, enabling targeted gene expression and cytotoxicity, and inhibiting tumor growth in mice.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • The retinoblastoma protein (pRB) normally suppresses tumors by regulating the E2F transcription factor.
  • Loss of pRB function in cancer leads to uncontrolled E2F activity, promoting cell proliferation.
  • Existing E2F target promoters (e.g., E2F1) lack cancer cell specificity, activating genes in normal proliferating cells.

Purpose of the Study:

  • To engineer promoters with enhanced specificity for cancer cells by exploiting tumor suppressor gene regulatory elements.
  • To evaluate the efficacy of these novel promoters in driving cancer-specific gene expression and therapeutic effects.

Main Methods:

  • Constructed artificial promoters by linking E2F-responsive elements from the TAp73 gene to the ARF core promoter.
  • Compared the cancer cell specificity of these artificial promoters against known promoters (E2F1, hTERT, ARF).
  • Utilized adenoviruses to deliver a cytotoxic gene under the control of the artificial promoters.
  • Assessed cancer cell-specific cytotoxicity and tumor growth inhibition in a xenograft mouse model.

Main Results:

  • The novel artificial promoters demonstrated superior cancer cell specificity compared to E2F1, hTERT, and ARF promoters.
  • Adenoviruses employing these promoters induced cytotoxicity specifically in cancer cells.
  • Significant inhibition of tumor growth was observed in vivo using the engineered adenoviral system.

Conclusions:

  • Artificial promoters derived from tumor suppressor gene elements offer a mechanism for highly specific gene expression in cancer cells.
  • This approach holds promise for targeted cancer gene therapy, minimizing off-target effects in normal tissues.
  • The developed promoters are effective in driving cancer-specific cytotoxicity and suppressing tumor progression.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K